Boston Scientific shares are trading higher after the company announced it initiated the AVANT GUARD clinical trial to evaluate the FARAPULSE Pulsed Field Ablation System as a first-line treatment for persistent atrial fibrillation.

Boston Scientific Corporation +1.01% Pre

Boston Scientific Corporation

BSX

68.12

68.12

+1.01%

0.00% Pre

Boston Scientific shares are trading higher after the company announced it initiated the AVANT GUARD clinical trial to evaluate the FARAPULSE Pulsed Field Ablation System as a first-line treatment for persistent atrial fibrillation.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via